References
- 1. Yilmaz I, Gokay NS, Bircan R, Saracoglu GV, Dervisoglu S, Gokce A. How different methodologies of harvesting and analysing the samples affect the test results in determining joint mediators. Arthritis. 2013: 631959. doi: 10.1155/2013/631959.
- 2. Lu YC, Evans CH, Grodzinsky AJ. Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines. Arthritis Res Ther. 2011; 13: R142.
- 3. Frobell RB, Roos EM, Roos HP, Ranstam J, Lohmander LS. A randomized trial of treatment for acute anterior cruciate ligament tears. N Engl J Med. 2010; 363: 331-42.
- 4. Anitua M, Sanchez E, Nurden A, Orive G, Andía I. New insights into and novel applications for platelet - rich fibrin therapies. Trends Biotechnol. 2006; 24: 227-34.
- 5. Gibbs N, Diamond R, Sekyere EO, Thomas WD. Management of knee osteoarthritis by combined stromal vascular fraction cell therapy, platelet-rich plasma, and musculoskeletal exercises: a case series. J Pain Res. 2015; 8: 799-806.
- 6. Duif C, Vogel T, Topcuoglu F, Spyrou G, von Schulze Pellengahr C, Lahner M. (2015). Does intraoperative application of leukocyte - poor platelet - rich plasma during arthroscopy for kneedegeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double - blind trial. Arch Orthop Trauma Surg. 2015; 135: 971-7.
- 7. Yin WJ, Xu HT, Sheng JG, An ZQ, Guo SC, Xie XT, Zhang CQ. (2016). Advantages of Pure Platelet-Rich Plasma Compared with Leukocyte - and Platelet - Rich Plasma in Treating Rabbit Knee Osteoarthritis. Med Sci Monit. 2016; 22: 1280-90.
- 8. Richards MM, Maxwell JS, Weng L, Angelos MG, Golzarian J. Intra - articular treatment of knee osteoart hritis: from anti-inflammatories to products of regene rative medicine. Phys Sportsmed. 2016; 44: 101-8.
- 9. Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014; 4: 3-9.
- 10. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet - rich plasma (P-PRP) to leucocyte - and platelet - rich fibrin (L-PRF). Trends Biotechnol. 2009; 27: 158-67.
- 11. Abbasi B, Pezeshki - Rad M, Akhavan R, Sahebari M. Association between clinical and sonographic synovitis in patients with painful knee osteoarthritis. Int J Rheum Dis. 2017; 20: 561-6.
- 12. Kellgren JH, Lawrence JS. Radiological assessment of osteo - arthritis. Ann Rheum Dis. 1957; 16: 494–502.
- 13. Filardo G, Di Matteo B, Di Martino A, Merli ML, Cenacchi A, Fornasari P, Marcacci M, Kon E. Platelet - Rich Plasma Intra - articular Knee Injections Show No Superiority Versus Viscosupplementation: A Randomized Controlled Trial. Am J Sports Med. 2015; 43: 1575-82.
- 14. Erel S, Simsek IE, Ozkan H. (2015). Analysis of the reliability and validity of the Turkish version of the intermittent and constant osteoarthritis pain questionnaire. Acta Orthop Traumatol Turc. 2015; 49: 508-12.
- 15. Odum SM, Fehring TK. Can Original Knee Society Scores Be Used to Estimate New 2011 Knee Society Scores? Clin Orthop Relat Res. 2017; 475: 160-7.
- 16. DiBartola AC, Wright BM, Magnussen RA, Flanigan DC. Clinical Outcomes After Autologous Chondrocyte Implantation in Adolescents’ Knees: A Systematic Review. Arthroscopy. 2016; 32: 1905-16.
- 17. Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet - rich plasma intra - articular injections for cartilage degeneration and osteoarthritis: single-versus doublespinning approach кnee Surg Sports Traumatol Arthrosc. 2012; 20: 2082-91
- 18. McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet -rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012; 94: e143-8: 1-8.
- 19. Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB, Dhert WJ. Antimicrobial activity of platelet - leukocyte gelagainst Staphylococcus aureus. J Orthop Res. 2008; 26: 404-10.
- 20. Bryan N, Ahswin H, Smart N, Bayon Y, Wohlert S, Hunt JA. Reactive oxygen species (ROS) - a family of fate deciding molecules pivotal in constructive inflammation and wound healing. Eur Cell Mater. 2012; 24: 249-65.
- 21. Yin W, Qi X, Zhang Y, Sheng J, Xu Z, Tao S, Xie X, Li X, Zhang C. Advantages of pure platelet - rich plasma compared with leukocyte - and platelet - rich plasma in promoting repair of bone defects. J Transl Med. 2016; 14: 73.
- 22. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet - rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double - blind, randomized trial. Am J Sports Med. 2013; 41: 356-64.
- 23. Aggarwal AK, Shashikanth VS, Marwaha N. Plateletrich plasma prevents blood loss and pain and enhances early functional outcome after totalknee arthroplasty: a prospective randomised controlled study. Int Orthop. 2014; 38: 387-95.